AU9028098A - Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception - Google Patents

Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Info

Publication number
AU9028098A
AU9028098A AU90280/98A AU9028098A AU9028098A AU 9028098 A AU9028098 A AU 9028098A AU 90280/98 A AU90280/98 A AU 90280/98A AU 9028098 A AU9028098 A AU 9028098A AU 9028098 A AU9028098 A AU 9028098A
Authority
AU
Australia
Prior art keywords
progestins
endometrial
oral contraception
atrophizing
sparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90280/98A
Other languages
English (en)
Inventor
Michael Kafrissen
Haya Taitel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of AU9028098A publication Critical patent/AU9028098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU90280/98A 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception Abandoned AU9028098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
US60057109 1997-08-27
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (1)

Publication Number Publication Date
AU9028098A true AU9028098A (en) 1999-03-16

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90280/98A Abandoned AU9028098A (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Country Status (9)

Country Link
EP (1) EP1007052B1 (enExample)
JP (1) JP2001513566A (enExample)
AT (1) ATE279198T1 (enExample)
AU (1) AU9028098A (enExample)
DE (1) DE69827017T2 (enExample)
DK (1) DK1007052T3 (enExample)
ES (1) ES2230711T3 (enExample)
PT (1) PT1007052E (enExample)
WO (1) WO1999009993A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
CA2524474A1 (en) * 2003-05-02 2004-11-18 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
JP2007534622A (ja) * 2003-07-16 2007-11-29 デュラメド ファーマシューティカルズ インコーポレーティッド 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法
JP2007507534A (ja) * 2003-10-01 2007-03-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 持続的三相避妊方法
EP1535618A1 (en) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
FI101601B1 (fi) * 1987-09-24 1998-07-31 Jencap Research Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä
DE4104385C1 (enExample) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
DK1007052T3 (da) 2005-01-31
JP2001513566A (ja) 2001-09-04
ES2230711T3 (es) 2005-05-01
DE69827017D1 (de) 2004-11-18
EP1007052A1 (en) 2000-06-14
WO1999009993A1 (en) 1999-03-04
ATE279198T1 (de) 2004-10-15
PT1007052E (pt) 2005-01-31
DE69827017T2 (de) 2006-03-09
EP1007052B1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
MY113079A (en) Estrogen agonists as remedies for cardiovascular diseases
CA2001618A1 (en) Gestodene-containing agent for transdermal administration
WO1999015210A3 (en) Bioadhesive compositions and methods for topical administration of active agents
AU9041991A (en) Transdermal contraceptive formulations, methods and devices
EP0841936A4 (en) CONJUGATION-STABILIZED THERAPEUTIC AGENT COMPOSITIONS, ADDITIONAL FORMULATIONS AND DIAGNOSTICS
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
WO1999044608A8 (en) New use
CA2131911A1 (en) Minimizing progestin associated breakthrough bleeding
TR199801511T2 (xx) Farmas�tik bile�im.
GR3031354T3 (en) Soluble interferon -receptor, its preparation and use.
HUP0203721A2 (hu) Új hormonkészítmény és alkalmazása
AU6042201A (en) Cancer therapy
AU6153400A (en) Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
AU9028098A (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
ES2131482A1 (es) Formulacion acuosa de bambuterol.
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
AR010296A1 (es) Uso de una combinacion de una progestina y un estrogeno y un equipo anticonceptivo para administracion oral
UA26246C2 (uk) Коhтрацептивhий комбіhоваhий препарат

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase